Quarterly Result12 May 2026, 02:18 pm
Emmessar Biotech Approves Audited FY26 Financial Results
AI Summary
Emmessar Biotech & Nutrition Ltd's Board of Directors approved the audited standalone financial results for the year ended March 31, 2026, following a review by the Audit Committee. The board meeting, held on May 12, 2026, also included a declaration confirming an unmodified opinion from the statutory auditors, V. Nagarajan & Co.
Key Highlights
- Board approved audited standalone financial results for FY26.
- Audit Committee reviewed the financial results.
- Auditors issued an unmodified opinion on the financial results.
- Meeting commenced at 12:20 noon and concluded at 4:00 p.m.
Price Impact
More from EMMESSA